Exco InTouch Address mHealth Solutions in Management of Chronic Conditions at 2014 mHealth Summit
Exco InTouch, the leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers, will speak in two mHealth Solutions sessions focused on disease management at the annual mHealth Summit on Monday, 8th and Tuesday 9th December 2014. In addition, on Wednesday, 10th December, Tim Davis, the CEO and Founder of Exco InTouch, will participate in the Personal Connected Health Alliance (PCHA)’s thought leadership roundtable discussion focused on driving cross sector collaboration to improve patient care, reporting and outcomes through mobile and connected health.
The mHealth Summit, now 6 years in the making, is firmly established as the largest mobile health event in the world, and will be held 7–11 December 2014 in Washington DC, USA. Tim Davis will address delivering a holistic self-management programme for chronic obstructive pulmonary disease (COPD) in the ‘Condition Management with Mobile and Connected Health’ session and Chris Watson, Product Manager, will examine how to deliver mHealth programmes, from pilot through to production, across borders at the event’s ‘Scaling mHealth’ session.
Tim Davis commented: “We are delighted to be speaking at this year’s mHealth Summit. Disease management is a crucial area of healthcare and mHealth is set to deliver ever more impactful solutions to the complex challenges for treating patients suffering from chronic conditions across the globe. I look forward to showing how applying a holistic self-management approach to mobile-enabled disease management programmes works to improve patient outcomes and, ultimately, their quality of life.”
Chris Watson commented: “Bringing the full benefits of mHealth solutions across multiple geographic boundaries presents unique challenges. The multitude of varying and complex regulations and differing patient requirements for the precise type and form of mobile and digital technology to be applied requires providers to be highly adaptable, to have strong regional knowledge and to be highly compliant. I very much look forward to sharing our experience in this field.”
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance